Opinion
New weight loss drugs raise questions of access, costs
New, popular injectable weight loss drugs — GLP-1 drugs — are highly effective at reducing obesity and, probably, the health risks posed by obesity. Yet the drugs are so expensive that insurers are often choosing between two bad options: restricting access or raising consumer costs.
Popular weight loss drugs like Ozempic might be able to help with substance abuse, according to new research on people ...
I always had a massive appetite and most of my life, I was able to eat what I wanted. I never worried about my size, assuming ...
Zmyra is known as the top over-the-counter alternative to Wegovy for weight loss. This natural supplement packs a punch with ...
Unemployed people will be given weight-loss jabs under Government plans to get them back to work. Wes Streeting, the Health ...
Wes Streeting responded to a Sky News report which found the NHS rollout of the "game-changing" weightloss drug has been slower than planned by saying it could risk fuelling a rise in eating disorders ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback